As of 2026-07-19, the Relative Valuation of Rigel Pharmaceuticals Inc (RIGL) is 247.87 USD. This relative valuation is based on P/E multiples. With the latest stock price at 40.54 USD, the upside of Rigel Pharmaceuticals Inc based on Relative Valuation is 511.4%.
The range of the Relative Valuation is 113.58 - 390.61 USD.
| Range | Selected | |
| Trailing P/E multiples | 16.8x - 19.8x | 18.1x |
| Forward P/E multiples | 16.4x - 21.9x | 20.1x |
| Fair Price | 113.58 - 390.61 | 247.87 |
| Upside | 180.2% - 863.5% | 511.4% |
| Date | P/E |
| 2026-07-17 | 2.06 |
| 2026-07-16 | 2.12 |
| 2026-07-15 | 2.09 |
| 2026-07-14 | 2.09 |
| 2026-07-13 | 2.10 |
| 2026-07-10 | 2.16 |
| 2026-07-09 | 2.22 |
| 2026-07-08 | 2.18 |
| 2026-07-07 | 2.16 |
| 2026-07-06 | 2.04 |
| 2026-07-02 | 1.97 |
| 2026-07-01 | 1.94 |
| 2026-06-30 | 1.99 |
| 2026-06-29 | 1.98 |
| 2026-06-26 | 1.97 |
| 2026-06-25 | 1.88 |
| 2026-06-24 | 1.86 |
| 2026-06-23 | 1.81 |
| 2026-06-22 | 1.81 |
| 2026-06-18 | 1.67 |
| 2026-06-17 | 1.69 |
| 2026-06-16 | 1.65 |
| 2026-06-15 | 1.70 |
| 2026-06-12 | 1.67 |
| 2026-06-11 | 1.63 |
| 2026-06-10 | 1.57 |
| 2026-06-09 | 1.56 |
| 2026-06-08 | 1.53 |
| 2026-06-05 | 1.52 |
| 2026-06-04 | 1.54 |
| 2026-06-03 | 1.54 |
| 2026-06-02 | 1.52 |
| 2026-06-01 | 1.52 |
| 2026-05-29 | 1.55 |
| 2026-05-28 | 1.53 |
| 2026-05-27 | 1.50 |
| 2026-05-26 | 1.48 |
| 2026-05-22 | 1.47 |
| 2026-05-21 | 1.48 |
| 2026-05-20 | 1.46 |
| 2026-05-19 | 1.44 |
| 2026-05-18 | 1.45 |
| 2026-05-15 | 1.47 |
| 2026-05-14 | 1.62 |
| 2026-05-13 | 1.63 |
| 2026-05-12 | 1.49 |
| 2026-05-11 | 1.33 |
| 2026-05-08 | 1.32 |
| 2026-05-07 | 1.33 |
| 2026-05-06 | 1.35 |